CO65 Modelled Impact of Nirsevimab for All Infants in the Prevention of Respiratory Syncytial Virus (RSV): Related Hospitalizations and Its Predicted Cost to the Brazilian Public Healthcare System
Abstract
Authors
M. Falavigna S.F. Watanabe J. Santoro K. Ribeiro A. Tolardo N. Schneider M. Safadi R.T. Stein A. Kieffer